Mr. Speaker, I would like to highlight the fact that we have a plan. That plan is to pursue international vaccine candidates. We have done that very clearly from day one. We have also invested in made-in-Canada solutions: AbCellera from Vancouver, VIDO-InterVac from Saskatoon, Variation Biotechnologies from Ottawa, Medicago from Quebec City—
In the House of Commons on November 30th, 2020. See this statement in context.